These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants. Ilham MA; Winkler S; Coates E; Rizzello A; Rees TJ; Asderakis A Transplant Proc; 2008; 40(6):1839-43. PubMed ID: 18675065 [TBL] [Abstract][Full Text] [Related]
31. Products of HLA class I and class II (B,C,DP,DQ,DR) genes all contribute to induction of recipient anti-donor responses in rejected kidneys. Bonneville M; Moreau JF; Blokland E; Pool J; Charron D; Goulmy E; Soulillou JP Transplant Proc; 1988 Apr; 20(2):193-5. PubMed ID: 3284038 [No Abstract] [Full Text] [Related]
32. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation. Won DI; Jeong HD; Kim YL; Suh JS Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535 [TBL] [Abstract][Full Text] [Related]
33. Allosensitization to HLA and MICA is an important measure of renal graft outcome. Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK Clin Transpl; 2007; ():211-7. PubMed ID: 18637472 [TBL] [Abstract][Full Text] [Related]
34. Flow cytometric detection of complement-activating HLA antibodies. Schönemann C; Lachmann N; Kiesewetter H; Salama A Cytometry B Clin Cytom; 2004 Nov; 62(1):39-45. PubMed ID: 15476206 [TBL] [Abstract][Full Text] [Related]
35. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC Transplant Proc; 2009; 41(1):95-8. PubMed ID: 19249487 [TBL] [Abstract][Full Text] [Related]
36. Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches. Vaidya S Transplantation; 2008 Apr; 85(7):1046-50. PubMed ID: 18408587 [TBL] [Abstract][Full Text] [Related]
37. Improved specificity and sensitivity when using pronase-digested lymphocytes to perform flow-cytometric crossmatch prior to renal transplantation. Lobo PI; Isaacs RB; Spencer CE; Pruett TL; Sanfey HA; Sawyer RG; McCullough C Transpl Int; 2002 Nov; 15(11):563-9. PubMed ID: 12461661 [TBL] [Abstract][Full Text] [Related]
38. Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab. Beimler JH; Morath C; Schmidt J; Ovens J; Opelz G; Rahmel A; Zeier M; Süsal C Transplantation; 2009 Mar; 87(5):668-71. PubMed ID: 19295310 [TBL] [Abstract][Full Text] [Related]
39. Histocompatibility testing in clinical renal transplantation. Braun WE Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529 [No Abstract] [Full Text] [Related]